122 related articles for article (PubMed ID: 22535176)
1. [DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico].
Bolado-Martínez E; Pérez-Mendoza A; Alegría-Morquecho FM; Candia-Plata Mdel C; Aguayo-Verdugo Mdel R; Alvarez-Hernández G
Salud Publica Mex; 2012; 54(2):167-70. PubMed ID: 22535176
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
Coll P; Aragón LM; Alcaide F; Espasa M; Garrigó M; González J; Manterola JM; Orús P; Salvadó M
Microb Drug Resist; 2005; 11(2):107-14. PubMed ID: 15910223
[TBL] [Abstract][Full Text] [Related]
6. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Aslan G; Tezcan S; Serin MS; Emekdas G
Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
[TBL] [Abstract][Full Text] [Related]
7. Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates.
Hamze M; Ismail MB; Rahmo AK; Dabboussi F
Int J Mycobacteriol; 2015 Sep; 4(3):228-32. PubMed ID: 27649870
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among
Haratiasl AA; Hamzelou G; Amini S; Kardan-Yamchi J; Haeili M; Heidari F; Feizabadi MM
J Chemother; 2020 Apr; 32(2):75-82. PubMed ID: 32009582
[TBL] [Abstract][Full Text] [Related]
9. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
Aragón LM; Navarro F; Heiser V; Garrigó M; Español M; Coll P
J Antimicrob Chemother; 2006 May; 57(5):825-31. PubMed ID: 16547071
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
Afanas'ev MV; Ikryannikova LN; Il'ina EN; Sidorenko SV; Kuz'min AV; Larionova EE; Smirnova TG; Chernousova LN; Kamaev EY; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
Kigozi E; Kasule GW; Musisi K; Lukoye D; Kyobe S; Katabazi FA; Wampande EM; Joloba ML; Kateete DP
PLoS One; 2018; 13(5):e0198091. PubMed ID: 29847567
[TBL] [Abstract][Full Text] [Related]
14. A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array.
Zhang SL; Shen JG; Xu PH; Li DX; Sun ZQ; Li L; Yang ZR; Sun Q
J Appl Microbiol; 2007 Oct; 103(4):1262-71. PubMed ID: 17897230
[TBL] [Abstract][Full Text] [Related]
15. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico.
Viader-Salvadó JM; Luna-Aguirre CM; Reyes-Ruiz JM; Valdez-Leal R; del Bosque-Moncayo Mde L; Tijerina-Menchaca R; Guerrero-Olazarán M
Microb Drug Resist; 2003; 9(1):33-8. PubMed ID: 12705681
[TBL] [Abstract][Full Text] [Related]
16. [Comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
Flores-Treviño S; Garza-González E
Salud Publica Mex; 2013 Apr; 55(2):150-1. PubMed ID: 23546402
[No Abstract] [Full Text] [Related]
17. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
[TBL] [Abstract][Full Text] [Related]
18. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
Hazbón MH; Brimacombe M; Bobadilla del Valle M; Cavatore M; Guerrero MI; Varma-Basil M; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; León CI; Bose M; Chaves F; Murray M; Eisenach KD; Sifuentes-Osornio J; Cave MD; Ponce de León A; Alland D
Antimicrob Agents Chemother; 2006 Aug; 50(8):2640-9. PubMed ID: 16870753
[TBL] [Abstract][Full Text] [Related]
19. [Response to comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
Bolado-Martínez E; Pérez-Mendoza A; Alegría-Morquecho FM; Candia-Plata Mdel C; Aguayo-Verdugo Mdel R; Alvarez-Hernández G
Salud Publica Mex; 2013 Apr; 55(2):151. PubMed ID: 23546403
[No Abstract] [Full Text] [Related]
20. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
Aslan G; Tezcan S; Emekdaş G
Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
